Norfloxacin Price Trend, Index and Forecast

Track the latest insights on norfloxacin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Norfloxacin Prices Outlook Q4 2025

• USA: USD 39098/MT
• India: USD 34639/MT
• Germany: USD 44846/MT
• China: USD 34449/MT
• Brazil: USD 41709/MT

Norfloxacin Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the fourth quarter of 2025, the norfloxacin prices in the USA reached 39098 USD/MT in December. Prices rose, supported by steady demand from pharmaceutical formulators and hospital procurement channels. Additionally, structured production schedules and regulatory compliance requirements maintained disciplined supply levels. Distributors secured volumes through contract-based sourcing to ensure uninterrupted availability for antibacterial drug manufacturing. During the fourth quarter of 2025, the norfloxacin prices in India reached 34639 USD/MT in December. Prices increased, driven by firm export demand and consistent procurement from domestic pharmaceutical manufacturers. Moreover, active order flows from overseas buyers encouraged stable production utilization rates. Manufacturers aligned output planning with confirmed shipment schedules, supporting healthy market activity. During the fourth quarter of 2025, the norfloxacin prices in Germany reached 44846 USD/MT in December. Prices moved upward, influenced by stable demand from healthcare providers and specialty pharmaceutical producers. Furthermore, stringent quality standards and regulated manufacturing capacity supported structured supply conditions. Buyers maintained disciplined inventory management to meet prescription drug requirements. During the fourth quarter of 2025, the norfloxacin prices in China reached 34449 USD/MT in December. Prices edged higher, amid steady export shipments and consistent demand from formulation units. In addition to this, controlled production volumes and stable raw material availability ensured balanced market fundamentals. Distributors maintained regular procurement cycles aligned with pharmaceutical manufacturing needs. During the fourth quarter of 2025, the norfloxacin prices in Brazil reached 41709 USD/MT in December. Prices rose, supported by firm demand from domestic pharmaceutical companies and hospital supply chains. Additionally, import coordination and regulatory documentation processes required structured purchasing strategies. Market participants maintained steady order placement to ensure continuous product availability.

Norfloxacin Prices Outlook Q3 2025

• USA: USD 38369/MT
• India: USD 33923/MT
• Germany: USD 43447/MT
• China: USD 34115/MT
• Brazil: USD 39932/MT

During the third quarter of 2025, the norfloxacin prices in the USA reached 38369 USD/MT in September. Prices declined, amid moderated procurement from pharmaceutical distributors and balanced domestic production levels. Additionally, comfortable inventory positions reduced immediate restocking urgency. Buyers focused on fulfilling existing supply agreements without expanding stock coverage. During the third quarter of 2025, the norfloxacin prices in India reached 33923 USD/MT in September. Prices fell, influenced by softer export inquiries and stable domestic output. Moreover, adequate inventories among formulation units limited aggressive spot purchasing. Manufacturers maintained measured production schedules aligned with confirmed demand visibility. During the third quarter of 2025, the norfloxacin prices in Germany reached 43447 USD/MT in September. Prices rose, supported by steady demand from hospital procurement programs and pharmaceutical manufacturers. Furthermore, structured regulatory compliance and controlled supply capacity maintained balanced availability. Distributors secured volumes in line with prescription drug requirements. During the third quarter of 2025, the norfloxacin prices in China reached 34115 USD/MT in September. Prices declined, driven by moderated export shipments and sufficient domestic stock levels. Additionally, formulation units adopted cautious purchasing strategies while monitoring downstream demand patterns. Supply chains operated efficiently, ensuring consistent availability across distribution channels. During the third quarter of 2025, the norfloxacin prices in Brazil reached 39932 USD/MT in September. Prices increased, supported by firm hospital procurement activity and steady pharmaceutical manufacturing demand. Moreover, structured import planning and regulatory adherence supported organized market conditions. Buyers maintained consistent sourcing aligned with healthcare sector requirements.

Norfloxacin Prices Outlook Q2 2025

• USA: USD 39650/MT
• India: USD 34580/MT
• Germany: USD 42970/MT
• China: USD 34850/MT
• Brazil: USD 38810/MT

During the second quarter of 2025, the norfloxacin prices in the USA reached 39650 USD/MT in June. In the USA, norfloxacin prices were influenced by steady demand from the pharmaceutical sector, particularly in the production of antimicrobial formulations. Feedstock costs for intermediates derived from petrochemicals added pressure on manufacturing economics, while compliance with stringent regulatory and quality standards elevated production expenses. Import dynamics for certain raw materials, combined with international shipping charges and port handling fees, further shaped procurement costs. Domestic logistics, including warehousing and distribution to hospitals and pharmacies, also contributed to overall pricing. During the second quarter of 2025, norfloxacin prices in India reached 34580 USD/MT in June. In India, norfloxacin prices were shaped by strong demand from the generic pharmaceutical manufacturing sector, which plays a vital role in both domestic supply and export markets. Feedstock availability for intermediates was affected by petrochemical industry output, while energy and labor costs added to production overheads. Export obligations to Africa and Southeast Asia created supply-side constraints. Additionally, regulatory compliance under national quality standards and inland transportation costs significantly impacted procurement expenses. During the second quarter of 2025, the norfloxacin prices in Germany reached 42970 USD/MT in June. In Germany, norfloxacin prices were influenced by demand from the pharmaceutical sector and dependence on imports of raw materials from Asia. Feedstock supply for intermediates and reagents was affected by global petrochemical trade dynamics, while strict environmental and quality regulations under the European Union framework added compliance costs. Energy expenses remained a major factor in production economics, and intra-European logistics, including trucking and warehousing, contributed significantly to distribution costs across the region. During the second quarter of 2025, the norfloxacin prices in China reached 34850 USD/MT in June. In China, norfloxacin prices were shaped by the scale of domestic pharmaceutical manufacturing and the country’s role as a major exporter of active pharmaceutical ingredients. Feedstock availability for intermediates was directly linked to petrochemical production and refining activity, while energy and utility costs influenced manufacturing expenses. Export flows to Europe, North America, and Southeast Asia created external demand pressures. Domestic logistics, alongside regulatory compliance for both local and export markets, added further cost layers to the supply chain. During the second quarter of 2025, the norfloxacin prices in Brazil reached 38810 USD/MT in June. In Brazil, norfloxacin prices were impacted by demand from the healthcare and pharmaceutical sectors, coupled with reliance on imports for key intermediates. International shipping rates and port handling charges significantly influenced procurement costs, while currency fluctuations against major trading partners added volatility. Domestic production expenses, including energy and labor costs, also shaped the market. Distribution challenges across Brazil’s vast geography further elevated logistics expenses, contributing to higher supply chain pressures.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the norfloxacin prices.

Europe Norfloxacin Price Trend

Q4 2025:

As per the norfloxacin price index, Europe recorded an upward pricing trend. Demand from hospital procurement systems and specialty antibiotic manufacturers remained consistent, particularly within regulated pharmaceutical supply chains. Moreover, strict compliance standards and controlled manufacturing capacity reinforced disciplined output levels. Additionally, structured distribution networks and centralized purchasing frameworks ensured stable product allocation across healthcare institutions.

Q3 2025:

Europe experienced a generally firm pricing environment. Demand from regulated pharmaceutical manufacturers and hospital networks remained stable across major healthcare markets. Moreover, disciplined production planning and quality compliance requirements supported structured supply management. Additionally, established distribution frameworks ensured reliable product flow to meet ongoing prescription demand.

Q2 2025:

As per the norfloxacin price index, European norfloxacin prices were shaped by steady demand from the pharmaceutical sector, particularly in the production of generic antibiotics. Dependence on imports of intermediates and active pharmaceutical ingredients from Asia left the market sensitive to global trade dynamics, shipping costs, and port handling fees. The European Union’s strict regulatory framework added compliance-related expenses, while elevated energy prices influenced manufacturing overheads. Domestic distribution through complex regional logistics networks further added to supply chain costs. This analysis can be extended to include detailed norfloxacin price information for a comprehensive list of countries.

Region	Countries Covered
Europe	Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Norfloxacin Price Trend

Q4 2025:

As per the norfloxacin price index, North America witnessed firm price growth. Pharmaceutical distributors maintained steady procurement to support antibacterial drug production and hospital supply programs. Furthermore, predictable prescription demand and integrated manufacturing infrastructure contributed to balanced supply conditions. In addition, long-term contractual agreements between producers and healthcare providers supported organized procurement planning.

Q3 2025:

North America recorded a downward pricing trend. Moderated distributor procurement and comfortable stock levels reduced immediate restocking pressure. Furthermore, stable domestic manufacturing capacity ensured adequate availability without supply constraints. In addition, predictable prescription volumes supported balanced market conditions despite softened purchasing intensity.

Q2 2025:

As per the norfloxacin price index, in North America, prices were impacted by strong requirements from the healthcare sector, especially for hospital supply and retail pharmaceuticals. Limited local production of raw materials meant reliance on imports, making procurement sensitive to currency fluctuations and international freight charges. Manufacturing costs were influenced by utility and labor expenses, while adherence to stringent regulatory and quality standards added compliance burdens. Inland distribution, including trucking and warehousing, also contributed significantly to overall supply chain dynamics. Specific norfloxacin historical data within the United States and Canada can also be provided.

Region	Countries Covered
North America	United States and Canada

Middle East and Africa Norfloxacin Price Trend

Q4 2025:

As per norfloxacin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q3 2025:

The report explores the norfloxacin pricing trends and norfloxacin price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. In addition to region-wise data, information on norfloxacin prices for countries can also be provided.

Region	Countries Covered
Middle East & Africa	Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Norfloxacin Price Trend

Q4 2025:

Prices increased, reflecting steady export flows and resilient demand from formulation hubs. Pharmaceutical manufacturers operated with stable production schedules, while overseas order pipelines remained active. Additionally, balanced inventory positions and efficient port logistics supported smooth distribution across domestic and export markets.

Q3 2025:

In the Asia Pacific region, prices declined, influenced by moderated export demand and sufficient availability within formulation clusters. Pharmaceutical manufacturers aligned procurement with confirmed production schedules, avoiding excessive stock accumulation. Additionally, efficient logistics networks and steady regulatory oversight supported orderly trade and domestic distribution activities.

Q2 2025:

In Asia Pacific, norfloxacin prices were influenced by robust pharmaceutical production in China and India, which dominate global supply. Feedstock availability from petrochemical-based intermediates shaped manufacturing costs, while domestic energy and labor expenses further influenced production economics. Export flows to Europe, North America, and Africa created demand-side pressures, while logistics expenses for both inland transport and international shipping added to costs. Regulatory compliance for diverse export markets also contributed to higher production and certification requirements. This norfloxacin price analysis can be expanded to include a comprehensive list of countries within the region.

Region	Countries Covered
Asia Pacific	China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Norfloxacin Price Trend

Q4 2025:

Norfloxacin prices strengthened on the back of demand from public healthcare systems and private pharmaceutical producers remaining firm, encouraging consistent procurement cycles. Furthermore, reliance on imports required careful regulatory compliance and documentation processes. Distributors maintained structured inventory practices aligned with prescription drug consumption trends.

Q3 2025:

In Latin America, norfloxacin prices moved upward. Demand from healthcare institutions and pharmaceutical production units remained steady, supporting organized procurement activity. Furthermore, structured import planning and regulatory compliance processes maintained smooth supply chain operations across key consumption markets. This comprehensive review can be extended to include specific countries within the region.

Region	Countries Covered
Latin America	Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Norfloxacin Pricing Report, Market Analysis, and News

IMARC's latest publication, “Norfloxacin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition𝔉,” presents a detailed examination of the norfloxacin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of norfloxacin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed norfloxacin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting norfloxacin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Norfloxacin Industry Analysis

The global norfloxacin industry size reached USD 12.1 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 17.0 Billion, at a projected CAGR of 3.74%💟 during 2026-2034. Growth is driven by increasing prevalence of bacterial infections, expanding healthcare access in emerging economies, and sustained demand for cost-effective broad-spectrum antibiotics. Additionally, rising pharmaceutical manufacturing capacity and ongoing regulatory compliance investments continue to support long-term market expansion.

Latest News and Developments:

• May 2025: A peer-reviewed study in “Monatshefte für Chemie - Chemical Monthly” synthesized N-4-piperazinyl norfloxacin analogues bearing arylidene or alkylidene acrylonitrile moieties and evaluated their antibacterial activity. Several compounds showed lower minimum inhibitory concentrations than norfloxacin, including 0.33–0.81 µM against S. aureus, 1.28–1.62 µM against E. coli, and 1.35–1.62 µM against K. pneumoniae, along with improved bactericidal activity. Docking and mechanistic studies indicated strong binding to the bacterial DNA gyrase active site and inhibition of DNA gyrase and topoisomerase IV.

Product Description

Norfloxacin is a synthetic chemotherapeutic antibiotic that is boxed and sold under different brand names, such as Noroxin, under the drug class of fluoroquinolone. The first release of the drug was in the 1980s, and the purpose it serves is fighting bacterial infections by stopping DNA bacteria replication. Norfloxacin acts by being counterproductive to the activity of bacterial DNA gyrase and topoisomerase IV enzymes, which participate basically in bacterial DNA replication, transcription, repair, and recombination. The inhibition process indicates that DNA functioning is spoiled so that the bacterial cells cannot replicate and are killed. The drug more effectively acts on Gram-negative bacteria, while it has less effect on Gram-positive ones. The drug is potent with urinary tract pathogens and hence preferred for uncomplicated urinary tract infections. Besides, it is considered effective in chronic bacterial prostatitis due to good penetration of the prostate.

Report Coverage

Key Attributes	Details
Product Name	Norfloxacin
Report Features	Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Norfloxacin Price Analysis, and Segment-Wise Assessment.
Currency/Units	US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered	The current coverage includes analysis at the global and regional levels only.    Based on your requirements, we can also customize the report and provide specific information for the following countries:    Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*   Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*    North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers	Company Overview Business Description Recent Trends and Developments
Customization Scope	The report can be customized as per the requirements of the customer
Report Price and Purchase Option	Plan A: Monthly Updates - Annual Subscription Scope Historical Data for the Current Month Forecast for Next Month Total Deliverables Per Year: 12 (One Per Month) Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year Plan B: Quarterly Updates - Annual Subscription Scope Historical Data for the Current Quarter Forecast for Next Quarter Total Deliverables Per Year: 4 (One Per Quarter) Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year Plan C: Biannually Updates - Annual Subscription Scope Historical Data for the Current Half Forecast for the Next Half Total Deliverables Per Year: 2 (One Per 6 Months) Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support	360-degree analyst support after report delivery
Delivery Format	PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of norfloxacin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting norfloxacin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The norfloxacin price charts ensure our clients remain at the forefront of the industry.